Skip to content
2000
image of Recent Innovations in Gelling Agents and Topical Gel Formulations for Psoriasis Treatment: A Patent Review

Abstract

Psoriasis, a chronic inflammatory skin condition, is caused by an accelerated rate of skin cell turnover, leading to plaques, scaling, and inflammation. Commonly used conventional treatments for these symptoms include topical corticosteroids and vitamin D analogues. However, recent developments in gelling agents and topical gel formulations have significantly improved therapeutic outcomes, enhancing medicine administration and patient satisfaction. This patent study aims to analyze and gather the latest advancements in the production of topical gel formulations and gelling agents specifically designed to treat psoriasis. In addition to highlighting the innovative gel-based delivery systems' effectiveness and safety, this review also emphasizes how they improve patient adherence, convenience, and general quality of life. By looking at these developments, this review sheds light on how topical gel formulations and gelling agents are set to revolutionize psoriasis treatment in the future.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpc/10.2174/0118779468355927250312073529
2025-03-24
2025-09-06

  • From This Site

    /content/journals/cpc/10.2174/0118779468355927250312073529
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Jain S. Dermatology: Illustrated study guide and comprehensive board review. Cham Springer 2017 10.1007/978‑3‑319‑47395‑6
    [Google Scholar]
  2. Menter A. Gottlieb A. Feldman S.R. Van Voorhees A.S. Leonardi C.L. Gordon K.B. Lebwohl M. Koo J.Y.M. Elmets C.A. Korman N.J. Beutner K.R. Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis. J. Am. Acad. Dermatol. 2008 58 5 826 850 10.1016/j.jaad.2008.02.039 18423260
    [Google Scholar]
  3. Kang Z. Zhang X. Du Y. Dai S.M. Global and regional epidemiology of psoriatic arthritis in patients with psoriasis: A comprehensive systematic analysis and modelling study. J. Autoimmun. 2024 145 103202 10.1016/j.jaut.2024.103202 38493674
    [Google Scholar]
  4. Hawkes J.E. Chan T.C. Krueger J.G. Psoriasis pathogenesis and the development of novel targeted immune therapies. J. Allergy Clin. Immunol. 2017 140 3 645 653 10.1016/j.jaci.2017.07.004 28887948
    [Google Scholar]
  5. Lew W. Bowcock A.M. Krueger J.G. Psoriasis vulgaris: Cutaneous lymphoid tissue supports T-cell activation and ‘Type 1’ inflammatory gene expression. Trends Immunol. 2004 25 6 295 305 10.1016/j.it.2004.03.006 15145319
    [Google Scholar]
  6. Yamanaka K. Yamamoto O. Honda T. Pathophysiology of psoriasis: A review. J. Dermatol. 2021 48 6 722 731 10.1111/1346‑8138.15913 33886133
    [Google Scholar]
  7. Sabooniha F. Psoriasis, bone and bowel: A comprehensive review and new insights. Exploration of Musculoskeletal Diseases 2024 2 1 1 19 10.37349/emd.2024.00029
    [Google Scholar]
  8. Sharma R.K. Sharma M.R. Mahendra A. Kumar S. Role of inflammatory cytokines in pathophysiology of psoriasis. Curr. Pharmacol. Rep. 2022 8 2 99 105 10.1007/s40495‑021‑00277‑2
    [Google Scholar]
  9. Young K.Z. Sarkar M.K. Gudjonsson J.E. Pathophysiology of generalized pustular psoriasis. Exp. Dermatol. 2023 32 8 1194 1203 10.1111/exd.14768 36779688
    [Google Scholar]
  10. Menter A. Griffiths C.E.M. Current and future management of psoriasis. Lancet 2007 370 9583 272 284 10.1016/S0140‑6736(07)61129‑5 17658398
    [Google Scholar]
  11. Campione E. Cosio T. Di Prete M. Lanna C. Dattola A. Bianchi L. Experimental pharmacological management of psoriasis. J. Exp. Pharmacol. 2021 13 725 737 10.2147/JEP.S265632 34345187
    [Google Scholar]
  12. Patel N.U. Felix K. Reimer D. Feldman S.R. Calcipotriene/betamethasone dipropionate for the treatment of psoriasis vulgaris: An evidence-based review. Clin. Cosmet. Investig. Dermatol. 2017 10 385 391 10.2147/CCID.S131727 29033598
    [Google Scholar]
  13. Segaert S. Duvold L.B. Calcipotriol cream: A review of its use in the management of psoriasis. J. Dermatolog. Treat. 2006 17 6 327 337 10.1080/09546630600999219 17853305
    [Google Scholar]
  14. White S. Vender R. Thaçi D. Haverkamp C. Naeyaert J.M. Foster R. Escribano M.J.A. Use of calcipotriene cream (Do- vonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): A randomized, parallel-group clinical trial. Am. J. Clin. Dermatol. 2006 7 3 177 184 10.2165/00128071‑200607030‑00004 16734505
    [Google Scholar]
  15. Kin K.C. Hill D. Feldman S.R. Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis. Expert Rev. Clin. Pharmacol. 2016 9 6 789 797 10.1080/17512433.2016.1179574 27089906
    [Google Scholar]
  16. Segaert S. Calzavara-Pinton P. de la Cueva P. Jalili A. Lons Danic D. Pink A.E. Thaçi D. Gooderham M. Long-term topical management of psoriasis: The road ahead. J. Dermatolog. Treat. 2022 33 1 111 120 10.1080/09546634.2020.1729335 32091278
    [Google Scholar]
  17. Nikam R.V. Gowtham M. More P.S. Shinde A.S. Current and emerging prospects in the psoriatic treatment. Int. Immunopharmacol. 2023 120 110331 10.1016/j.intimp.2023.110331 37210912
    [Google Scholar]
  18. Roeder A. Schaller M. Schäfer-Korting M. Korting H.C. Tazarotene: therapeutic strategies in the treatment of psoriasis, acne and photoaging. Skin Pharmacol. Physiol. 2004 17 3 111 118 10.1159/000077236 15087589
    [Google Scholar]
  19. Dando T.M. Wellington K. Topical Tazarotene. Am. J. Clin. Dermatol. 2005 6 4 255 272 10.2165/00128071‑200506040‑00006 16060713
    [Google Scholar]
  20. Dattola A. Silvestri M. Bennardo L. Del Duca E. Longo C. Bianchi L. Nisticò S. Update of calcineurin inhibitors to treat inverse psoriasis: A systematic review. Dermatol. Ther. 2018 31 6 e12728 10.1111/dth.12728 30295379
    [Google Scholar]
  21. Wang C. Lin A. Efficacy of topical calcineurin inhibitors in psoriasis. J. Cutan. Med. Surg. 2014 18 1 8 14 10.2310/7750.2013.13059 24377467
    [Google Scholar]
  22. Gutfreund K. Bienias W. Szewczyk A. Kaszuba A. Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use. Postepy Dermatol. Alergol. 2013 3 3 165 169 10.5114/pdia.2013.35619 24278069
    [Google Scholar]
  23. Ramic L. Sator P. Topical treatment of psoriasis vulgaris. JDDG. J. Dtsch. Dermatol. Ges. 2023 21 6 631 642
    [Google Scholar]
  24. Nițescu D. Mușetescu A. Nițescu M. Costescu M. Coman O.A. Experimental research in topical psoriasis therapy. Exp. Ther. Med. 2021 22 3 971 10.3892/etm.2021.10403 34335913
    [Google Scholar]
  25. Rapalli V.K. Singhvi G. Dubey S.K. Gupta G. Chellappan D.K. Dua K. Emerging landscape in psoriasis management: From topical application to targeting biomolecules. Biomed. Pharmacother. 2018 106 707 713 10.1016/j.biopha.2018.06.136 29990862
    [Google Scholar]
  26. Pradhan M. Alexander A. Singh M.R. Singh D. Saraf S. Saraf S. Yadav K. Ajazuddin, Statistically optimized calcipotriol fused nanostructured lipid carriers for effectual topical treatment of psoriasis. J. Drug Deliv. Sci. Technol. 2021 61 102168 10.1016/j.jddst.2020.102168
    [Google Scholar]
  27. Barrea L. Savanelli M.C. Somma D.C. Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist. Rev. Endocr. Metab. Disord. 2017 18 2 195 205 10.1007/s11154‑017‑9411‑6 28176237
    [Google Scholar]
  28. Ahmed S.K.S. Manchanda Y. De A. Das S. Kumar R. Topical therapy in psoriasis. Indian J. Dermatol. 2023 68 4 437 445 10.4103/ijd.ijd_422_23 37822388
    [Google Scholar]
  29. Pradhan M. Yadav K. Singh D. Singh M.R. Topical delivery of fluocinolone acetonide integrated NLCs and salicylic acid enriched gel: A potential and synergistic approach in the management of psoriasis. J. Drug Deliv. Sci. Technol. 2021 61 102282 10.1016/j.jddst.2020.102282
    [Google Scholar]
  30. Sunoqrot S. Niazi M. Al-Natour M.A. Jaber M. Abu-Qatouseh L. Loading of coal tar in polymeric nanoparticles as a potential therapeutic modality for psoriasis. ACS Omega 2022 7 8 7333 7340 10.1021/acsomega.1c07267 35252723
    [Google Scholar]
  31. McDowell L. Olin B. Crisaborole: A novel nonsteroidal topical treatment for atopic dermatitis. J. Pharm. Technol. 2019 35 4 172 178 10.1177/8755122519844507 34861031
    [Google Scholar]
  32. Bagel J. Gold L.S. Combining topical psoriasis treatment to enhance systemic and phototherapy: A review of the literature. J. Drugs Dermatol. 2017 16 12 1209 1222 29240856
    [Google Scholar]
  33. Elmets C.A. Korman N.J. Prater E.F. Wong E.B. Rupani R.N. Kivelevitch D. Armstrong A.W. Connor C. Cordoro K.M. Davis D.M.R. Elewski B.E. Gelfand J.M. Gordon K.B. Gottlieb A.B. Kaplan D.H. Kavanaugh A. Kiselica M. Kroshinsky D. Lebwohl M. Leonardi C.L. Lichten J. Lim H.W. Mehta N.N. Paller A.S. Parra S.L. Pathy A.L. Siegel M. Stoff B. Strober B. Wu J.J. Hariharan V. Menter A. Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J. Am. Acad. Dermatol. 2021 84 2 432 470 10.1016/j.jaad.2020.07.087 32738429
    [Google Scholar]
  34. Fereig S.A. El-Zaafarany G.M. Arafa M.G. Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis. Drug Deliv. 2020 27 1 662 680 10.1080/10717544.2020.1754527 32393082
    [Google Scholar]
  35. Kleyn E.C. Morsman E. Griffin L. Wu J.J. Cm van de Kerkhof P. Gulliver W. van der Walt J.M. Iversen L. Review of international psoriasis guidelines for the treatment of psoriasis: Recommendations for topical corticosteroid treatments. J. Dermatolog. Treat. 2019 30 4 311 319 10.1080/09546634.2019.1620502 31138038
    [Google Scholar]
  36. Campione E. Paternò E.J. Diluvio L. Costanza G. Bianchi L. Carboni I. Chimenti S. Orlandi A. Marino D. Favalli C. Tazarotene as alternative topical treatment for onychomycosis. Drug Des. Devel. Ther. 2015 9 879 886 10.2147/DDDT.S69946 25733808
    [Google Scholar]
  37. Amiri D. Schwarz C.W. Gether L. Skov L. Sa- fety and efficacy of topical calcineurin inhibitors in the treatment of facial and genital psoriasis: A systematic review. Acta Derm. Venereol. 2023 103 adv00890 10.2340/actadv.v103.6525 36916954
    [Google Scholar]
  38. un-Nabi, Seyda Ayesha Ahmed. Pharmaceutical gels: A review. RADS J. Pharm. Pharm. Sci. 2016 4 40 48
    [Google Scholar]
  39. Wu S.H. Rethi L. Pan W.Y. Nguyen H.T. Chuang A.E.Y. Emerging horizons and prospects of polysaccharide-constructed gels in the realm of wound healing. Colloids Surf. B Biointerfaces 2024 235 113759 10.1016/j.colsurfb.2024.113759 38280240
    [Google Scholar]
  40. Bhuyan C. Saha D. Rabha B. A brief review on topical gels as drug delivery system. J. Pharm. Res. Int. 2021 33 344 357 10.9734/jpri/2021/v33i47A33020
    [Google Scholar]
  41. Nilsen-Nygaard J. Strand S. Vårum K. Draget K. Nordgård C. Chitosan: Gels and interfacial properties. Polymers (Basel) 2015 7 3 552 579 10.3390/polym7030552
    [Google Scholar]
  42. Zhao F. Shi Y. Pan L. Yu G. Multifunctional nanostructured conductive polymer gels: Synthesis, properties, and applications. Acc. Chem. Res. 2017 50 7 1734 1743 10.1021/acs.accounts.7b00191 28649845
    [Google Scholar]
  43. Owens G.J. Singh R.K. Foroutan F. Alqaysi M. Han C.M. Mahapatra C. Kim H.W. Knowles J.C. Sol–gel based materials for biomedical applications. Prog. Mater. Sci. 2016 77 1 79 10.1016/j.pmatsci.2015.12.001
    [Google Scholar]
  44. Deshmukh K. Kovářík T. Křenek T. Docheva D. Stich T. Pola J. Recent advances and future perspectives of sol–gel derived porous bioactive glasses: A review. RSC Advances 2020 10 56 33782 33835 10.1039/D0RA04287K 35519068
    [Google Scholar]
  45. Bokov D. Turki Jalil A. Chupradit S. Suksatan W. Javed Ansari M. Shewael I.H. Valiev G.H. Kianfar E. Nanomaterial by sol‐gel method: Synthesis and application. Adv. Mater. Sci. Eng. 2021 2021 1 5102014 10.1155/2021/5102014
    [Google Scholar]
  46. Voorhaar L. Hoogenboom R. Supramolecular polymer networks: Hydrogels and bulk materials. Chem. Soc. Rev. 2016 45 14 4013 4031 10.1039/C6CS00130K 27206244
    [Google Scholar]
  47. Riccio R. Formulations for topical use containing lactoferrin, their preparation and use. WO Patent 2012153301A1., 2012
  48. Chaniyilparampu R.N. Mungala M. Kapoor A. Gokaraju G.R. Gokaraju R.R. Kiran B. Golakoti T. Nair A.K. Murali M.R. Parthasarathy K. Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof. Patent US20120052095A1, 2012
  49. Xu, T.; Liu, K.; Sheng, N.; Zhang, M.; Liu, W.; Liu, H.; Dai, L.; Zhang, X.; Si, C.; Du, H.; Zhang, K. Biopolymer- based hydrogel electrolytes for advanced energy storage/conversion devices: Properties, applications, and perspectives. Energy. Storage Mater., 2022, 48, 244-262.
  50. Rahangdal M. Pandey P. Kakasania J. Transethosomal gel of apremilast for treatment of psoriasis. IN Patent 202021008860, 2021
  51. Joshi Y. A topical formulation for management of psoriasis. Patent 202311054541 2023
    [Google Scholar]
  52. Ninosu N. Hoelker S. Kappenstein M. Buettner S. Peitsch W.K. Schaarschmidt M.L. Treatment satisfaction of patients with psoriasis with topical therapy in a real-world setting: Unmet need for higher effectiveness. J. Dermatolog. Treat. 2023 34 1 2200570 10.1080/09546634.2023.2200570 37026416
    [Google Scholar]
  53. Raphael A.P. Garrastazu G. Sonvico F. Prow T.W. Formulation design for topical drug and nanoparticle treatment of skin disease. Ther. Deliv. 2015 6 2 197 216 10.4155/tde.14.106 25690087
    [Google Scholar]
  54. Pradhan M. Alexander A. Singh M.R. Singh D. Saraf S. Saraf S. Ajazuddin, Understanding the prospective of nano-formulations towards the treatment of psoriasis. Biomed. Pharmacother. 2018 107 447 463 10.1016/j.biopha.2018.07.156 30103117
    [Google Scholar]
  55. Raut A.S. Prabhu R.H. Patravale V.B. Psoriasis clinical implications and treatment: A review. Crit. Rev. Ther. Drug Carrier Syst. 2013 30 3 183 216 10.1615/critrevtherdrugcarriersyst.2013005268 23614646
    [Google Scholar]
  56. Ramanunny A.K. Wadhwa S. Singh S.K. Sharma D.S. Khursheed R. Awasthi A. Treatment strate- gies against psoriasis: Principle, perspectives and practices. Curr. Drug Deliv. 2020 17 1 52 73 10.2174/1567201816666191120120551 31752655
    [Google Scholar]
  57. Oliveira R. Almeida I.F. Patient-centric design of topical dermatological medicines. Pharmaceuticals 2023 16 4 617 10.3390/ph16040617 37111373
    [Google Scholar]
  58. Albrecht L. Bourcier M. Ashkenas J. Papp K. Shear N. Toole J. Vender R. Wasel N. Topical psoriasis therapy in the age of biologics: Evidence-based treatment recommendations. J. Cutan. Med. Surg. 2011 15 6 309 321 10.2310/7750.2011.10080 22202506
    [Google Scholar]
  59. Cong L. Zou B. Palacios A. Navarro M.E. Qiao G. Ding Y. Thickening and gelling agents for formulation of thermal energy storage materials – A critical review. Renew. Sustain. Energy Rev. 2022 155 111906 10.1016/j.rser.2021.111906
    [Google Scholar]
  60. Czajkowska-Kośnik A. Szymańska E. Winnicka K. Nanostructured lipid carriers (NLC)-based gel formulations as etodolac delivery: From gel preparation to permeation study. Molecules 2022 28 1 235 10.3390/molecules28010235 36615429
    [Google Scholar]
  61. Mokdad R. Aouabed A. Ball V. Si Youcef F.F. Nasrallah N. Heurtault B. HadjSadok, A. Formulation and rheological evaluation of liposomes-loaded carbopol hydrogels based on thermal waters. Drug Dev. Ind. Pharm. 2022 48 11 635 645 10.1080/03639045.2022.2152044 36420770
    [Google Scholar]
  62. Ojha B. Jain V.K. Gupta S. Talegaonkar S. Jain K. Nanoemulgel: A promising novel formulation for treatment of skin ailments. Polym. Bull. 2022 79 7 4441 4465 10.1007/s00289‑021‑03729‑3
    [Google Scholar]
  63. Chen Y. Lee J.H. Meng M. Cui N. Dai C.Y. Jia Q. Lee E.S. Jiang H.B. An overview on thermosensitive oral gel based on poloxamer 407. Materials (Basel) 2021 14 16 4522 10.3390/ma14164522 34443046
    [Google Scholar]
  64. Djabourov M. Nishinari K. Ross-Murphy S.B. Phy- sical gels from biological and synthetic polymers. Cambridge University Press 2013 10.1017/CBO9781139024136
    [Google Scholar]
  65. Singhal R. Gupta K. A review: Tailor-made hydro- gel structures (classifications and synthesis parame- ters). Polym. Plast. Technol. Eng. 2016 55 1 54 70 10.1080/03602559.2015.1050520
    [Google Scholar]
  66. Garg S. Garg A. Vishwavidyalaya R.D. Hydrogel: Classification, properties, preparation and technical features. Asian J. Biomater Res. 2016 2 6 163 170
    [Google Scholar]
  67. Bustamante-Torres M. Romero-Fierro D. Hydrogels classification according to the physical or chemical interactions and as stimuli-sensitive materials. Gels 2021 7 4 182 10.3390/gels7040182 34842654
    [Google Scholar]
  68. Bou-Sarkis A. Paul E. Girbal-Neuhauser E. Derlon N. Bessiere Y. Detection of gel-forming poly- mers via calcium crosslinking, applied to the scree- ning of extracellular polymeric substances extracted from biological aggregates. Gels 2023 9 2 157 10.3390/gels9020157 36826327
    [Google Scholar]
  69. Venkatachalam D. Kaliappa S. Superabsorbent polymers: A state-of-art review on their classification, synthesis, physicochemical properties, and applications. Rev. Chem. Eng. 2023 39 1 127 171 10.1515/revce‑2020‑0102
    [Google Scholar]
  70. B, S.A.; Jeganath, S.; Jeevitha, E. Pharmaceutical gels and recent trends-A review. RJPT 2019 12 12 6181 6186 10.5958/0974‑360X.2019.01073.4
    [Google Scholar]
  71. Singh A. Kulkarni A. Recent advances in gelling agents for pharmaceutical applications. Int. J. Pharm. Sci. Res. 2018 9 4 1535 1543
    [Google Scholar]
  72. Kulawik-Pióro A. Miastkowska M. Polymeric gels and their application in the treatment of psoriasis vulgaris: A review. Int. J. Mol. Sci. 2021 22 10 5124 10.3390/ijms22105124 34066105
    [Google Scholar]
  73. Mohan R. Singh S. Kumar G. Srivastava M. Evaluation of gelling behavior of natural gums and their formulation prospects. Indian J. Pharma Edu Res. 2020 54 4 1016 1023 10.5530/ijper.54.4.195
    [Google Scholar]
  74. Raeisi Estabragh M.A. Sajadi Bami M. Dehghannoudeh G. Noudeh Y.D. Moghimipour E. Cellulose derivatives and natural gums as gelling agents for preparation of emulgel-based dosage forms: A brief review. Int. J. Biol. Macromol. 2023 241 124538 10.1016/j.ijbiomac.2023.124538 37085064
    [Google Scholar]
  75. Anderson E.R. Martos Adam Pell, C.S. Methods, Compositions, and Apparatuses for treating psoriasis by phototherapy. US Patent 9968800B2, 2018
  76. Sachdeva M. Ketankumar P. Methods and Formulations for topical treatment of psoriasis. US Patent 9867827B1, 2018
  77. Jaya A. Vivek M. Kiran C. Vipul M. Topical composition of Apremilast. WO Patent 2017216738A1, 2017
  78. Nadav S. Eran S. Manu J. Herbal Nanoformulations for treating psoriasis and other skin conditions. WO Patent 2017172648A1, 2017
  79. Yuhas E.R. Method and compositions for treating Psoriasis. US Patent 9717741B2, 2017
  80. Ake L. Niklas P. Lars P. Anders S. Topical Delivery System. WO Patent 2016198472A1, 2016
  81. Christine L. A Method for treating peripheral inflammatory disease. EP Patent 3095444A1, 2016
  82. Woo K.S. Se-gyu J. Shin-hee L. An acidic external application for psoriasis treatment. KR Patent 20160037791A, 2016
  83. Elmo G.M. Pharmaceutical composition for preventing, treating, and curing Psoriasis including snail slime, chamomile, and honey. WO Patent 2016029328A1, 2016
  84. Lajos K. Piroska R. Erzsébet C. Composition for increasing the effectiveness of UV-B therapy, process for the preparation thereof, and its use. US Patent 20150352026AI, 2015
  85. Longgui W. Liu M.X. Mencher S.K. Methods and compositions for treating psoriasis. US Patent 20150335617A1, 2015
  86. Jack A.D. Use of alpha 2 adrenergic receptor agonists for treating or preventing psoriasis.Patent AU2010332233A 2011
    [Google Scholar]
  87. Thennati R. Rehani R.B. Vaghela M.N. Panday R.R. Tazarotene with low dimer impurity for treating acne or Psoriasis. US Patent 9,688,667 B2., 2015
  88. Rathinasabapathy V. Vikas J. Vaibhav D. Sumit M. Kumar A.V. Rajesh R. Topical pharmaceutical composition of Acitretin. WO Patent 2015063723A1, 2015
  89. Banov Daniel Mixture of betamethasone and a647/34 473 (2006.01) tranlast with a transidermal gel forscar 474 treatment. US Patent 2015/0306221 A1, 2015
  90. Bakan D.A. Newhard S.B. Sen N. Mandhare A.S. Jadhav T.D. Kumar M. Topical compositions of flunsolide and methods of treatment. US Patent 20140274982A1., 2014
  91. Angel A. Dow G. Pharmaceutical formulations containing corticosteroids for topical administration. US Patent 8809307b2, 2014
  92. Caserini M Mailland F Use of pidotimod to treat psoriasis. WO Patent 2014/094840a1, 2014
  93. Xiang C. Application of methotrexate and ABC inhibitor to the preparation of a medicament for treating psoriasis. CN Patent 101926996B, 2013
  94. Sutar K.P. Jadhav V.A. Kulkarni M. Hande S.S. Formulation, evaluation and optimization of tacrolimus loaded transethosomes for the management of psoriasis. IN Patent 202341051109, 2023
  95. Rehman K. Zulfakar M.H. Recent advances in gel technologies for topical and transdermal drug delivery. Drug Dev. Ind. Pharm. 2014 40 4 433 440 10.3109/03639045.2013.828219 23937582
    [Google Scholar]
  96. Dimote R.K. Tamboli A.A. S, S.R. Exploring the versatility of topical gels: - An Overview. Adv. Zool. 2024 45 3 10.53555/jaz.v45i3.4366
    [Google Scholar]
  97. Ira C.S. Mark A.F. Alla A. Use of short chain fatty acids for the treatment and prevention of diseases and disorders. US Patent 11,759,442B2, 2023
  98. Wheeler D. Steel D.F. Michael G. Steen P.D. Topical composition. US Patent. 11,065,195 B2, 2023
  99. Singh S. Awasthi R. Breakthroughs and bottlenecks of psoriasis therapy: Emerging trends and advances in lipid based nano-drug delivery platforms for dermal and transdermal drug delivery. J. Drug Deliv. Sci. Technol. 2023 84 104548 10.1016/j.jddst.2023.104548
    [Google Scholar]
  100. Song Y. Chen W. Yin Y. Li J. Wang M. Liu Y. Ren X. Advancements in the transdermal drug delivery systems utilizing microemulsion-based gels. Curr. Pharm. Des. 2024 30 35 2753 2764 10.2174/0113816128305190240718112945 39092731
    [Google Scholar]
/content/journals/cpc/10.2174/0118779468355927250312073529
Loading
Recent Innovations in Gelling Agents and Topical Gel Formulations for Psoriasis Treatment: A Patent Review
Bentham Science Publishers ; https://doi.org/10.2174/0118779468355927250312073529
/content/journals/cpc/10.2174/0118779468355927250312073529
/content/journals/cpc/10.2174/0118779468355927250312073529
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: Psoriasis ; pathophysiology ; patents ; gelling agents ; topical gels ; polymers

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test